Making safe and effective medicines is a lot harder than modern chip production because the subject is humans and we have to do medicine ethically.
The pharmaceutical industry predates chiptech by quite some time, represents a fairly large market, the companies are quite technological, but the underlying problems are very different from making chips. And if trials like this succeed, that area of biotech will see billions in funding.
It's not funded as much as chips but it's also a smaller overall market.
The pharmaceutical industry predates chiptech by quite some time, represents a fairly large market, the companies are quite technological, but the underlying problems are very different from making chips. And if trials like this succeed, that area of biotech will see billions in funding.
It's not funded as much as chips but it's also a smaller overall market.